2030 Hospitals Insurance Coverage and Processing 
Pharmaceutical Technology
JULY 14, 2025
Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. The global RSV market is set to reach $6.3bn in value by 2030, according to analysis by GlobalData. MAXSHOT.PL
Pharmaceutical Technology
AUGUST 7, 2025
Meanwhile, GlobalData forecasts that the mRNA vaccine market will continue to grow, increasing in value from $11bn in 2024 to $17.9bn in 2030. mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. Give your business an edge with our leading industry insights.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
AUGUST 14, 2025
Buy Reports Newsletters PT Analysis Left Right Features Comment & Opinion Data Insights Analyst Comment US eosinophilic oesophagitis market to reach $1.19bn by 2030 With multiple novel therapies expected and the treatment paradigm shifting toward earlier intervention, the market will grow rapidly. Credit: aslysun via Shutterstock.
Proxsys Rx
APRIL 4, 2024
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
Proxsys Rx
AUGUST 22, 2023
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
Proxsys Rx
DECEMBER 22, 2023
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
Express Pharma
JANUARY 12, 2024
Due to the multiplicity of regulatory processes and multiple regulators, undertaking operations become complex and time consuming. million nurses/midwives in the total stock by 2030. Similarly, in case of certain category of drugs/medical treatments, additional approvals from PESO, Atomic Energy Regulatory Board, may be required.
Expert insights. Personalized for you.
Let's personalize your content